Zacks: Analysts expect Silicon Laboratories Inc. (NASDAQ: SLAB) to report earnings of $0.91 per share
Wall Street analysts expect Silicon Laboratories Inc. (NASDAQ:SLAB – Get a rating) will report earnings per share of $0.91 for the current fiscal quarter, according to Zacks Investment Research. Four analysts provided earnings estimates for Silicon Laboratories. The highest EPS estimate is $0.93 and the lowest is $0.90. Silicon Laboratories reported earnings of $1.05 per share in the same quarter last year, suggesting a negative 13.3% year-over-year growth rate. The company is expected to release its next results on Monday, January 1.
According to Zacks, analysts expect Silicon Laboratories to report annual earnings of $3.66 per share for the current fiscal year, with EPS estimates ranging from $3.13 to $3.85. For the next fiscal year, analysts expect the company to post earnings of $4.19 per share, with EPS estimates ranging from $2.70 to $5.25. Zacks Investment Research’s earnings per share calculations are an average average based on a survey of sell-side analysts who provide coverage for Silicon Laboratories.
Silicon Laboratories (NASDAQ: SLAB – Get a rating) last reported results on Wednesday, April 27. The semiconductor company reported earnings per share (EPS) of $1.05 for the quarter, beating analysts’ consensus estimate of $0.64 by $0.41. The company posted revenue of $233.80 million for the quarter, versus analyst estimates of $226.22 million. Silicon Laboratories had a net margin of 266.91% and a return on equity of 4.08%. The company’s quarterly revenue increased 48.2% year over year. During the same period of the previous year, the company achieved EPS of $0.65.
SLAB has been the subject of several recent research reports. Barclays raised its price target on Silicon Laboratories from $160.00 to $185.00 in a Wednesday, January 12 report. Stifel Nicolaus raised his price target on Silicon Laboratories shares from $200.00 to $210.00 in a Wednesday, April 27 research note. Zacks Investment Research downgraded shares of Silicon Laboratories from a “buy” rating to a “hold” rating in a Wednesday, April 6 research note. Cowen lowered his price target on Silicon Laboratories shares from $205.00 to $180.00 in a Thursday, April 28 research report. Finally, Needham & Company LLC raised its price target on Silicon Laboratories stock from $210.00 to $230.00 and gave the stock a “buy” rating in a Monday, March 7 research report. Six analysts gave the stock a hold rating and five gave the company a buy rating. According to data from MarketBeat.com, Silicon Laboratories currently has a consensus rating of “Hold” and a consensus target price of $189.00.
NASDAQ SLAB shares opened at $138.90 on Monday. The stock has a market capitalization of $5.08 billion, a P/E ratio of 2.91 and a beta of 1.23. The company’s 50-day simple moving average is $141.80 and its 200-day simple moving average is $169.07. Silicon Laboratories has a 12-month low of $120.15 and a 12-month high of $211.98. The company has a current ratio of 8.62, a quick ratio of 8.40 and a debt ratio of 0.26.
In other Silicon Laboratories news, please Brandon Tolany sold 986 shares of the company in a transaction that took place on Wednesday, February 16. The stock was sold at an average price of $157.98, for a total value of $155,768.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, available at this link. Additionally, director Nina Richardson sold 473 shares of the company in a trade that took place on Friday, April 22. The stock was sold at an average price of $129.60, for a total transaction of $61,300.80. Following the transaction, the administrator now owns 8,171 shares of the company, valued at $1,058,961.60. Disclosure of this sale can be found here. In the past three months, insiders have sold 2,459 shares of the company valued at $372,379. 1.61% of the shares are held by insiders.
Several institutional investors and hedge funds have recently changed their positions in SLAB. Los Angeles Capital Management LLC increased its stake in shares of Silicon Laboratories by 42.5% during the first quarter. Los Angeles Capital Management LLC now owns 50,236 shares of the semiconductor company worth $7,545,000 after buying an additional 14,985 shares in the last quarter. Weil Company Inc. increased its stake in Silicon Laboratories by 18.9% in the 1st quarter. Weil Company Inc. now owns 1,533 shares of the semiconductor company valued at $230,000 after purchasing an additional 244 shares during the period. Aigen Investment Management LP bought a new position in Silicon Laboratories during Q1 worth $362,000. Prestige Wealth Management Group LLC acquired a new stake in shares of Silicon Laboratories in Q1 worth $30,000. Finally, Royce & Associates LP increased its holdings of Silicon Laboratories shares by 9.1% in the first quarter. Royce & Associates LP now owns 24,000 shares of the semiconductor company valued at $3,605,000 after acquiring 2,000 more shares last quarter. Institutional investors and hedge funds own 99.40% of the company’s shares.
Silicon Laboratories Company Profile (Get a rating)
Silicon Laboratories Inc, a fabless semiconductor company, provides mixed-signal integrated circuits (ICs) in the United States, China and around the world. The Company offers microcontrollers and wireless products, including 8-bit mixed-signal and 32-bit ultra-low-power microcontrollers (MCUs); wireless MCU connectivity solutions; single-protocol and multi-protocol system-on-chip (SoC) devices and modules; wireless, MCU and SoC protocols; internal protocol stacks; Micrium, a real-time operating system that helps simplify software development for IoT developers. timing devices; multi-channel isolators, isolated drivers, isolated power converters and mixed-signal devices; broadcast products, which include single-chip hybrid TV tuners and digital video demodulators, as well as AM/FM, HD radio and DAB/DAB+ receivers; and software-defined hybrid radio tuners, data receivers and digital radio co-processors.
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Silicon Laboratories right now?
Before you consider Silicon Laboratories, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Silicon Laboratories wasn’t on the list.
While Silicon Laboratories currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here